Αρχειοθήκη ιστολογίου

Δευτέρα 24 Ιουλίου 2017

Novocure brings Optune tech to drug trial for glioblastoma

Novocure (NSDQ:NVCR) said today that it joined a Phase Ib study to evaluate the safety of Celgene's (NSDQ:CELG) marizomib and temozolomide in combination with Optune for patients with newly-diagnosed glioblastoma. The trial is the first to assess Optune, the company's "Tumor Treating Fields" delivery device, in combination with an investigational drug. Get the full story at our sister site, Drug Delivery Business News. The post Novocure brings Optune tech to drug trial for glioblastoma appeared first on MassDevice. (Source: Mass Device)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2v1KX0H
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader